Global Liposome Drug Delivery Market Growth 2022-2028
As the global economy mends, the 2021 growth of Liposome Drug Delivery will have significant change from previous year. According to our latest study, the global Liposome Drug Delivery market size is USD million in 2022 from USD 3652.8 million in 2021, with a change of % between 2021 and 2022. The global Liposome Drug Delivery market size will reach USD 8742.8 million in 2028, growing at a CAGR of 13.3% over the analysis period.
The United States Liposome Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Liposome Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Liposome Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Liposome Drug Delivery players cover Gilead Sciences, Pacira, Sun Pharmaceutical, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liposome Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Liposome Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Liposome Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Liposome Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposome Drug Delivery Sales by Type
2.3.1 Global Liposome Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Liposome Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Liposome Drug Delivery Sale Price by Type (2017-2022)
2.4 Liposome Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposome Drug Delivery Sales by Application
2.5.1 Global Liposome Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Liposome Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Liposome Drug Delivery Sale Price by Application (2017-2022)
3 Global Liposome Drug Delivery by Company
3.1 Global Liposome Drug Delivery Breakdown Data by Company
3.1.1 Global Liposome Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Liposome Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Liposome Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Liposome Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Liposome Drug Delivery Sale Price by Company
3.4 Key Manufacturers Liposome Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposome Drug Delivery Product Location Distribution
3.4.2 Players Liposome Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Liposome Drug Delivery by Geographic Region
4.1 World Historic Liposome Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Liposome Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Liposome Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Liposome Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Liposome Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Liposome Drug Delivery Annual Revenue by Country/Region
4.3 Americas Liposome Drug Delivery Sales Growth
4.4 APAC Liposome Drug Delivery Sales Growth
4.5 Europe Liposome Drug Delivery Sales Growth
4.6 Middle East & Africa Liposome Drug Delivery Sales Growth
5 Americas
5.1 Americas Liposome Drug Delivery Sales by Country
5.1.1 Americas Liposome Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Liposome Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Liposome Drug Delivery Sales by Type
5.3 Americas Liposome Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome Drug Delivery Sales by Region
6.1.1 APAC Liposome Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Liposome Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Liposome Drug Delivery Sales by Type
6.3 APAC Liposome Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Liposome Drug Delivery by Country
7.1.1 Europe Liposome Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Liposome Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Liposome Drug Delivery Sales by Type
7.3 Europe Liposome Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposome Drug Delivery by Country
8.1.1 Middle East & Africa Liposome Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Liposome Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Liposome Drug Delivery Sales by Type
8.3 Middle East & Africa Liposome Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposome Drug Delivery
10.3 Manufacturing Process Analysis of Liposome Drug Delivery
10.4 Industry Chain Structure of Liposome Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposome Drug Delivery Distributors
11.3 Liposome Drug Delivery Customer
12 World Forecast Review for Liposome Drug Delivery by Geographic Region
12.1 Global Liposome Drug Delivery Market Size Forecast by Region
12.1.1 Global Liposome Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Liposome Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liposome Drug Delivery Forecast by Type
12.7 Global Liposome Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Liposome Drug Delivery Product Offered
13.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Pacira
13.2.1 Pacira Company Information
13.2.2 Pacira Liposome Drug Delivery Product Offered
13.2.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pacira Main Business Overview
13.2.5 Pacira Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Liposome Drug Delivery Product Offered
13.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Liposome Drug Delivery Product Offered
13.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposome Drug Delivery Product Offered
13.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau
13.6.1 Sigma-Tau Company Information
13.6.2 Sigma-Tau Liposome Drug Delivery Product Offered
13.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sigma-Tau Main Business Overview
13.6.5 Sigma-Tau Latest Developments
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Information
13.7.2 Ipsen (Onivyde) Liposome Drug Delivery Product Offered
13.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ipsen (Onivyde) Main Business Overview
13.7.5 Ipsen (Onivyde) Latest Developments
13.8 CSPC
13.8.1 CSPC Company Information
13.8.2 CSPC Liposome Drug Delivery Product Offered
13.8.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CSPC Main Business Overview
13.8.5 CSPC Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Liposome Drug Delivery Product Offered
13.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposome Drug Delivery Product Offered
13.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Fudan-Zhangjiang
13.11.1 Fudan-Zhangjiang Company Information
13.11.2 Fudan-Zhangjiang Liposome Drug Delivery Product Offered
13.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fudan-Zhangjiang Main Business Overview
13.11.5 Fudan-Zhangjiang Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Liposome Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Liposome Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposome Drug Delivery Sales by Type (2017-2022) & (K Vial)
Table 8. Global Liposome Drug Delivery Sales Market Share by Type (2017-2022)
Table 9. Global Liposome Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 10. Global Liposome Drug Delivery Revenue Market Share by Type (2017-2022)
Table 11. Global Liposome Drug Delivery Sale Price by Type (2017-2022) & (USD/Vial)
Table 12. Global Liposome Drug Delivery Sales by Application (2017-2022) & (K Vial)
Table 13. Global Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Table 14. Global Liposome Drug Delivery Revenue by Application (2017-2022)
Table 15. Global Liposome Drug Delivery Revenue Market Share by Application (2017-2022)
Table 16. Global Liposome Drug Delivery Sale Price by Application (2017-2022) & (USD/Vial)
Table 17. Global Liposome Drug Delivery Sales by Company (2020-2022) & (K Vial)
Table 18. Global Liposome Drug Delivery Sales Market Share by Company (2020-2022)
Table 19. Global Liposome Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Liposome Drug Delivery Revenue Market Share by Company (2020-2022)
Table 21. Global Liposome Drug Delivery Sale Price by Company (2020-2022) & (USD/Vial)
Table 22. Key Manufacturers Liposome Drug Delivery Producing Area Distribution and Sales Area
Table 23. Players Liposome Drug Delivery Products Offered
Table 24. Liposome Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Liposome Drug Delivery Sales by Geographic Region (2017-2022) & (K Vial)
Table 28. Global Liposome Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 29. Global Liposome Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Liposome Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Liposome Drug Delivery Sales by Country/Region (2017-2022) & (K Vial)
Table 32. Global Liposome Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 33. Global Liposome Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Liposome Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Liposome Drug Delivery Sales by Country (2017-2022) & (K Vial)
Table 36. Americas Liposome Drug Delivery Sales Market Share by Country (2017-2022)
Table 37. Americas Liposome Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Liposome Drug Delivery Revenue Market Share by Country (2017-2022)
Table 39. Americas Liposome Drug Delivery Sales by Type (2017-2022) & (K Vial)
Table 40. Americas Liposome Drug Delivery Sales Market Share by Type (2017-2022)
Table 41. Americas Liposome Drug Delivery Sales by Application (2017-2022) & (K Vial)
Table 42. Americas Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Table 43. APAC Liposome Drug Delivery Sales by Region (2017-2022) & (K Vial)
Table 44. APAC Liposome Drug Delivery Sales Market Share by Region (2017-2022)
Table 45. APAC Liposome Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Liposome Drug Delivery Revenue Market Share by Region (2017-2022)
Table 47. APAC Liposome Drug Delivery Sales by Type (2017-2022) & (K Vial)
Table 48. APAC Liposome Drug Delivery Sales Market Share by Type (2017-2022)
Table 49. APAC Liposome Drug Delivery Sales by Application (2017-2022) & (K Vial)
Table 50. APAC Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Table 51. Europe Liposome Drug Delivery Sales by Country (2017-2022) & (K Vial)
Table 52. Europe Liposome Drug Delivery Sales Market Share by Country (2017-2022)
Table 53. Europe Liposome Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Liposome Drug Delivery Revenue Market Share by Country (2017-2022)
Table 55. Europe Liposome Drug Delivery Sales by Type (2017-2022) & (K Vial)
Table 56. Europe Liposome Drug Delivery Sales Market Share by Type (2017-2022)
Table 57. Europe Liposome Drug Delivery Sales by Application (2017-2022) & (K Vial)
Table 58. Europe Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Liposome Drug Delivery Sales by Country (2017-2022) & (K Vial)
Table 60. Middle East & Africa Liposome Drug Delivery Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Liposome Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Liposome Drug Delivery Sales by Type (2017-2022) & (K Vial)
Table 64. Middle East & Africa Liposome Drug Delivery Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Liposome Drug Delivery Sales by Application (2017-2022) & (K Vial)
Table 66. Middle East & Africa Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Liposome Drug Delivery
Table 68. Key Market Challenges & Risks of Liposome Drug Delivery
Table 69. Key Industry Trends of Liposome Drug Delivery
Table 70. Liposome Drug Delivery Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Liposome Drug Delivery Distributors List
Table 73. Liposome Drug Delivery Customer List
Table 74. Global Liposome Drug Delivery Sales Forecast by Region (2023-2028) & (K Vial)
Table 75. Global Liposome Drug Delivery Sales Market Forecast by Region
Table 76. Global Liposome Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Liposome Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Liposome Drug Delivery Sales Forecast by Country (2023-2028) & (K Vial)
Table 79. Americas Liposome Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Liposome Drug Delivery Sales Forecast by Region (2023-2028) & (K Vial)
Table 81. APAC Liposome Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Liposome Drug Delivery Sales Forecast by Country (2023-2028) & (K Vial)
Table 83. Europe Liposome Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Liposome Drug Delivery Sales Forecast by Country (2023-2028) & (K Vial)
Table 85. Middle East & Africa Liposome Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Liposome Drug Delivery Sales Forecast by Type (2023-2028) & (K Vial)
Table 87. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Liposome Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Liposome Drug Delivery Sales Forecast by Application (2023-2028) & (K Vial)
Table 91. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Liposome Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 94. Gilead Sciences Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 95. Gilead Sciences Liposome Drug Delivery Product Offered
Table 96. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 97. Gilead Sciences Main Business
Table 98. Gilead Sciences Latest Developments
Table 99. Pacira Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 100. Pacira Liposome Drug Delivery Product Offered
Table 101. Pacira Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 102. Pacira Main Business
Table 103. Pacira Latest Developments
Table 104. Sun Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 105. Sun Pharmaceutical Liposome Drug Delivery Product Offered
Table 106. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 107. Sun Pharmaceutical Main Business
Table 108. Sun Pharmaceutical Latest Developments
Table 109. Johnson & Johnson Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Liposome Drug Delivery Product Offered
Table 111. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 112. Johnson & Johnson Main Business
Table 113. Johnson & Johnson Latest Developments
Table 114. Luye Pharma Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 115. Luye Pharma Liposome Drug Delivery Product Offered
Table 116. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 117. Luye Pharma Main Business
Table 118. Luye Pharma Latest Developments
Table 119. Sigma-Tau Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 120. Sigma-Tau Liposome Drug Delivery Product Offered
Table 121. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 122. Sigma-Tau Main Business
Table 123. Sigma-Tau Latest Developments
Table 124. Ipsen (Onivyde) Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 125. Ipsen (Onivyde) Liposome Drug Delivery Product Offered
Table 126. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 127. Ipsen (Onivyde) Main Business
Table 128. Ipsen (Onivyde) Latest Developments
Table 129. CSPC Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 130. CSPC Liposome Drug Delivery Product Offered
Table 131. CSPC Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 132. CSPC Main Business
Table 133. CSPC Latest Developments
Table 134. Teva Pharmaceutical Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 135. Teva Pharmaceutical Liposome Drug Delivery Product Offered
Table 136. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 137. Teva Pharmaceutical Main Business
Table 138. Teva Pharmaceutical Latest Developments
Table 139. Novartis Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 140. Novartis Liposome Drug Delivery Product Offered
Table 141. Novartis Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 142. Novartis Main Business
Table 143. Novartis Latest Developments
Table 144. Fudan-Zhangjiang Basic Information, Liposome Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 145. Fudan-Zhangjiang Liposome Drug Delivery Product Offered
Table 146. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2022)
Table 147. Fudan-Zhangjiang Main Business
Table 148. Fudan-Zhangjiang Latest Developments
List of Figures
Figure 1. Picture of Liposome Drug Delivery
Figure 2. Liposome Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposome Drug Delivery Sales Growth Rate 2017-2028 (K Vial)
Figure 7. Global Liposome Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Liposome Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liposomal Doxorubicin
Figure 10. Product Picture of Liposomal Amphoteracin B
Figure 11. Product Picture of Liposomal Paclitaxel
Figure 12. Product Picture of Others
Figure 13. Global Liposome Drug Delivery Sales Market Share by Type in 2021
Figure 14. Global Liposome Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 15. Liposome Drug Delivery Consumed in Fungal Infection Therapy
Figure 16. Global Liposome Drug Delivery Market: Fungal Infection Therapy (2017-2022) & (K Vial)
Figure 17. Liposome Drug Delivery Consumed in Cancer & Tumor Therapy
Figure 18. Global Liposome Drug Delivery Market: Cancer & Tumor Therapy (2017-2022) & (K Vial)
Figure 19. Liposome Drug Delivery Consumed in Others
Figure 20. Global Liposome Drug Delivery Market: Others (2017-2022) & (K Vial)
Figure 21. Global Liposome Drug Delivery Sales Market Share by Application (2017-2022)
Figure 22. Global Liposome Drug Delivery Revenue Market Share by Application in 2021
Figure 23. Liposome Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Liposome Drug Delivery Revenue Market Share by Company in 2021
Figure 25. Global Liposome Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Liposome Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 27. Global Liposome Drug Delivery Sales Market Share by Region (2017-2022)
Figure 28. Global Liposome Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 29. Americas Liposome Drug Delivery Sales 2017-2022 (K Vial)
Figure 30. Americas Liposome Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 31. APAC Liposome Drug Delivery Sales 2017-2022 (K Vial)
Figure 32. APAC Liposome Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 33. Europe Liposome Drug Delivery Sales 2017-2022 (K Vial)
Figure 34. Europe Liposome Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Liposome Drug Delivery Sales 2017-2022 (K Vial)
Figure 36. Middle East & Africa Liposome Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 37. Americas Liposome Drug Delivery Sales Market Share by Country in 2021
Figure 38. Americas Liposome Drug Delivery Revenue Market Share by Country in 2021
Figure 39. United States Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Liposome Drug Delivery Sales Market Share by Region in 2021
Figure 44. APAC Liposome Drug Delivery Revenue Market Share by Regions in 2021
Figure 45. China Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Liposome Drug Delivery Sales Market Share by Country in 2021
Figure 52. Europe Liposome Drug Delivery Revenue Market Share by Country in 2021
Figure 53. Germany Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Liposome Drug Delivery Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Liposome Drug Delivery Revenue Market Share by Country in 2021
Figure 60. Egypt Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Liposome Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Liposome Drug Delivery in 2021
Figure 66. Manufacturing Process Analysis of Liposome Drug Delivery
Figure 67. Industry Chain Structure of Liposome Drug Delivery
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
